Pharmaceuticals.jpg

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

67392-87-4

Drospirenone

67392-87-4
11032-98-7

Desmycosin (Tylosine B)

11032-98-7
103060-53-3

Daptomycin

103060-53-3
4298-15-1

Desethylhydroxychloroquine

4298-15-1
77883-43-3

Doxazosin Mesylate

77883-43-3
152-62-5

Dydrogesterone

152-62-5
36418-29-8

Dihydrocodeine HCl

36418-29-8
42399-41-7

Diltiazem

42399-41-7
101831-37-2

Diclazuril

101831-37-2
18507-89-6

Decoquinate

18507-89-6
577-11-7

Docusate sodium

577-11-7
22494-42-4

Diflunisal

22494-42-4
6906-38-3

Delphinidin 3-monoglucoside

6906-38-3
108-69-0

Dimethylaniline-3,5

108-69-0
14206-59-8

4-epi-Demeclocycline

14206-59-8
53158-73-9

Delphinidin 3-sambubioside HCl

53158-73-9
3600-86-0

2,5-Dimethoxyphenethylamine

3600-86-0
10184-69-7

Deltacortinene

10184-69-7
68-89-3

Dipyrone

68-89-3
185453-02-5

O-Desmethyltramadol hydrochloride

185453-02-5